BABA vs HZO

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

The company presents a stark contrast between deep value metrics and deteriorating fundamental growth. While the Piotroski F-Score of 5/9 indicates a stable financial baseline, the business is struggling with a -16.50% YoY revenue decline and a -71.4% crash in YoY EPS growth. Valuation is highly attractive on a Price-to-Book (0.71) and Price-to-Sales (0.29) basis, but the negative ROE and poor Quick Ratio (0.30) suggest significant liquidity risks and operational inefficiency. The 'Strong Buy' analyst consensus conflicts with a bearish technical trend (10/100), suggesting a speculative value play rather than a growth investment.